LMLifeng Ma

Lifeng Ma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lifeng Ma has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Chen Huang

    Department of Gastrointestinal Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.

    1 shared publication
  • Dongning Rao

    Department of Hepatobiliary Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, 200032, China

    1 shared publication
  • Guohe Song

    Department of Liver Surgery and Transplantation, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China

    1 shared publication
  • Guoji Guo

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, China

    1 shared publication
  • Jia Fan

    Fudan University

    1 shared publication
  • Jian Lin

    Fudan University 2 Shanghai

    1 shared publication

Latest Publications

  • Top Cited Papers

    A blueprint for tumor-infiltrating B cells across human cancers

    by Jiaqiang Ma, Yingcheng Wu, Lifeng Ma, Xupeng Yang, Tiancheng Zhang, Guohe Song, Teng Li, Ke Gao, Xia Shen, Jian Lin, et al.

    B lymphocytes are essential mediators of humoral immunity and play multiple roles in human cancer. To decode the functions of tumor-infiltrating B cells, we generated a B cell blueprint encompassing single-cell transcriptome, B cell–receptor repertoire, and chromatin accessibility data across 20 different cancer types (477 samples, 269 patients). B cells harbored extraordinary heterogeneity and comprised 15 subsets, which could be grouped into two independent developmental paths (extrafollicular versus germinal center). Tumor types grouped into the extrafollicular pathway were linked with worse clinical outcomes and resistance to immunotherapy. The dysfunctional extrafollicular program was associated with glutamine-derived metabolites through epigenetic-metabolic cross-talk, which promoted a T cell–driven immunosuppressive program. These data suggest an intratumor B cell balance between extrafollicular and germinal-center responses and suggest that humoral immunity could possibly be harnessed for B cell–targeting immunotherapy.